A groundbreaking Alzheimer’s drug, developed by Acumen Pharmaceuticals and aimed at combating the toxic protein beta amyloid in the brain, has successfully passed its initial safety test and is set to proceed to a larger trial phase. Known as ACI193, this innovative drug demonstrated excellent tolerance during the preliminary studies… An experimental Alzheimer’s disease drug […]
Published on July 17, 2023
A recent study has discovered that ChatGPT’s responses to healthcare queries are so similar to those given by humans that it’s almost impossible to tell the difference. This indicates that chatbots like ChatGPT could become valuable allies for healthcare providers when communicating with patients. It’s like having a friend who can seamlessly step in and […]
Published on July 17, 2023
In a groundbreaking study, scientists have developed an artificial intelligence model akin to a master detective that can unravel which medications may potentially harm unborn babies. This model, also known as a ‘knowledge graph,’ adeptly integrates diverse sets of data to explore the origins of congenital disabilities. By predicting the involvement of pre-clinical compounds, it […]
Published on July 17, 2023